Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy von Lode, Holger N, Ladenstein, Ruth, Troschke-Meurer, Sascha, Struppe, Linda, Siebert, Nikolai, Zumpe, Maxi, Ehlert, Karoline, Huber, Stefanie, Glogova, Evgenia, Hundsdoerfer, Patrick, Eggert, Angelika, Zaniewska-Tekieli, Anna, Balwierz, Walentyna, Wieczorek, Aleksandra

Volltext